on Verisante Technology, Inc. (isin : CA92346G2036)
Verisante Technology Ends Reverse Takeover Agreement with SunRegen Healthcare
Verisante Technology, Inc. (TSXV:VER.H) announced the termination of its proposed Reverse Takeover (RTO) with SunRegen Healthcare AG. The decision to end the Letter of Intent, initially signed on August 12, 2024, was mutual. This announcement was made on March 31, 2025.
The proposed RTO had resulted in the suspension of Verisante's trading activities on the TSX Venture Exchange. The trading is expected to resume approximately two business days after the exchange issues a confirming bulletin.
Additionally, Verisante is set to hold its Annual General Meeting on June 12, 2025. The record date for this meeting has been established as April 28, 2025.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Verisante Technology, Inc. news